1. Sharma A, Kondo M, Iwahashi C, Parachuri N, Kumar N, Bandello F, et al. Approved biosimilar ranibizumab-a global update. Eye. 2023;37:200–2.
2. Sharma A, Parachuri N, Kumar N, Bandello B, Kuppermann BD. Emerging biosimilars for retinal diseases. Expert Rev Ophthalmol. 2022;17:383–6.
3. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/125156s0000_LucentisTOC.cfm#:~:text=Approval%20Date%3A%2006%2F30%2F2006. Accessed June 2023
4. https://www.gene.com/media/press-releases/14708/2018-03-21/fda-approves-genentechs-lucentis-ranibiz#:~:text=The%20Lucentis%200.5%20mg%20PFS,myopic%20choroidal%20neovascularization%20(mCNV). Accessed June 2023
5. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/125387s0000toc.cfm. Accessed June 2023